脓毒症、静脉输液与呼吸衰竭:SAIFR回顾性分析
本研究为单中心回顾性分析,纳入2017年6月至2018年6月收治的214例脓毒症患者,按是否接受指南推荐的30 mL/kg初始液体复苏分组,比较呼吸衰竭发生率。结果显示,接受适当液体复苏者占29.0%,总体呼吸衰竭发生率在适当复苏组与非适当复苏组间无统计学差异(40.3% vs 36.8%;在合并充血性心力衰竭及慢性肾脏病的高危亚组中结果相似。研究表明,以氧需求增加广泛定义呼吸衰竭时,保守初始液体复苏策略并未降低低氧性呼吸衰竭发生率。
要点
- 在214例脓毒症患者中,仅29.0%接受了指南推荐的30 mL/kg或以上初始液体复苏。
- 在合并充血性心力衰竭或慢性肾脏病的高危亚组中,适当液体复苏与呼吸衰竭风险的关系与总体结果相似。
- 本研究为单中心回顾性分析,样本量有限,结果需前瞻性研究验证。
适用人群与场景
- 2017年6月至2018年6月期间,美国内布拉斯加州奥马哈市一家学术医疗中心收治的214例脓毒症患者。
- 亚组分析纳入合并充血性心力衰竭(CHF)及慢性肾脏病(CKD)的高危患者。
诊断标准与关键阈值
- 呼吸衰竭定义为氧流量增加或需要更强烈的氧合和通气支持;氧需求及容量在入院时、6小时、12小时、24小时及出院时测量。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:单中心回顾性分析,基于前瞻性收集的临床数据;样本量214例;单中心。
- 人群:脓毒症患者;干预:接受指南推荐的初始静脉液体bolus≥30 mL/kg;对照:接受<30 mL/kg的保守复苏。
- 亚组:在合并CHF及CKD的高危患者中,结果相似。
证据类型、等级与局限
- 证据类型:回顾性分析(基于前瞻性收集的临床数据),单中心,样本量214例。
- 局限性:单中心、回顾性设计、样本量有限;原文未提及证据等级或推荐强度。
对床旁实践的改变
- 本研究提示,在脓毒症患者中,以氧需求增加广泛定义呼吸衰竭时,保守的初始静脉液体复苏策略(<30 mL/kg)并未降低低氧性呼吸衰竭发生率。
- 对于合并充血性心力衰竭或慢性肾脏病的高危患者,适当液体复苏与呼吸衰竭风险的关系与总体人群相似,但需注意本研究为回顾性分析,不能作为改变临床实践的充分证据。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Although resuscitation with IV fluids is the cornerstone of sepsis management, consensus regarding their association with improvement in clinical outcomes is lacking.
RESEARCH QUESTION: Is there a difference in the incidence of respiratory failure in patients with sepsis who received guideline-recommended initial IV fluid bolus of 30 mL/kg or more conservative resuscitation of less than 30 mL/kg?
STUDY DESIGN AND METHODS: This was a retrospective analysis of prospectively collected clinical data conducted at an academic medical center in Omaha, Nebraska. We abstracted data from 214 patients with sepsis admitted to a single academic medical center between June 2017 and June 2018. Patients were stratified by receipt of guideline-recommended fluid bolus. The primary outcome was respiratory failure defined as an increase in oxygen flow rate or more intense oxygenation and ventilation support; oxygen requirement and volume were measured at admission, 6 h, 12 h, 24 h, and at discharge. Subgroup analyses were conducted in high-risk patients with congestive heart failure (CHF) as well as those with chronic kidney disease (CKD).
RESULTS: A total of 62 patients (29.0%) received appropriate bolus treatment. The overall rate of respiratory failure was not statistically different between patients who received appropriate bolus or did not (40.3% vs 36.8%; P = .634). Likewise, no differences were observed in time to respiratory failure (P = .645) or risk of respiratory failure (adjusted hazard ratio, 1.1 [95% CI, 0.7-1.7]; P = .774). Results were similar within the high-risk CHF and CKD subgroups.
INTERPRETATION: In this single-center retrospective study, we found that by broadly defining respiratory failure as an increase in oxygen requirements, a conservative initial IV fluid resuscitation strategy did not correlate with decreased rates of hypoxemic respiratory failure.
参考来源
- Jagan N, Morrow LE, Walters RW, et al. Sepsis, the Administration of IV Fluids, and Respiratory Failure: A Retrospective Analysis-SAIFR Study. Chest. 2020. PMID: 33197405. doi:10.1016/j.chest.2020.10.078
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。